Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with KRAS-Mutated Colorectal Cancer

Overview of attention for article published in Molecular Cancer Therapeutics, May 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#33 of 3,888)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 16 news outlets

twitter: 1 X user

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 31 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 2,546 followers.

An interesting approach to targeting RAS mutant CRC. Promising phase I data of FOLFIRI + pelareorep @MCT_AACR @FightCRC https://t.co/XOqy3tJYwn

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.